Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Metaplastic Breast Cancer—The Case for Doing Less and More

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Krings G, Chen YY. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma. Modern pathology. 2018;31(11):1661–74.

    Article  CAS  PubMed  Google Scholar 

  2. Schroeder MC, Rastogi P, Geyer CE Jr, Miller LD, Thomas A. Early and locally advanced metaplastic breast cancer: presentation and survival by receptor status in surveillance, epidemiology, and end results (SEER) 2010–2014. Oncologist. 2018;23(4):481–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ong CT, Campbell BM, Thomas SM, et al. Metaplastic breast cancer treatment and outcomes in 2500 patients: a retrospective analysis of a national oncology database. Ann Surg Oncol. 2018;25(8):2249–60.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Edenfield J, Schammel C, Collins J, Schammel D, Edenfield WJ. Metaplastic breast cancer: molecular typing and identification of potential targeted therapies at a single institution. Clinical Breast Cancer. 2017;17(1):e1–10.

    Article  PubMed  Google Scholar 

  5. Murphy BL, Fazzio RT, Hoskin TL, et al. Management of the axilla in metaplastic breast carcinoma. Gland Surgery. 2018;7(2):200–6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

Dr. Fayanju is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Number 5KL2TR001115 (PI: Svetkey) and by the Duke Cancer Institute through NIH grant P30CA014236 (PI: Kastan).

Author information

Authors and Affiliations

  1. Department of Surgery, Duke University Medical Center, Durham, NC, USA

    Oluwadamilola M. Fayanju MD, MA, MPHS

  2. Duke Cancer Institute, Durham, NC, USA

    Oluwadamilola M. Fayanju MD, MA, MPHS

Authors
  1. Oluwadamilola M. Fayanju MD, MA, MPHS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oluwadamilola M. Fayanju MD, MA, MPHS.

Ethics declarations

Disclosures

Oluwadamilola M. Fayanju has no conflicts of interest to disclose.

Additional information

ASO Author Reflections is a brief invited commentary on the article “Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database”, Ann Surg Oncol. 2018;25:2249–2260.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fayanju, O.M. ASO Author Reflections: Metaplastic Breast Cancer—The Case for Doing Less and More. Ann Surg Oncol 25 (Suppl 3), 689–690 (2018). https://doi.org/10.1245/s10434-018-7009-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-7009-1

Keywords

Search

Navigation